Calidi Biotherapeutics, Inc. Common Stock (CLDI)
0.2402
+0.00 (0.00%)
NYSE · Last Trade: Jul 8th, 6:59 AM EDT
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · June 23, 2025
Via Benzinga · June 13, 2025

Via Benzinga · June 3, 2025
Via Benzinga · April 21, 2025

Calidi Biotherapeutics shares are trading lower by 12.4% Wednesday. The company announced a $2 million registered direct offering at $1.00 per share.
Via Benzinga · October 23, 2024

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · February 19, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025

Calidi Biotherapeutics shares are trading lower by 32% during Friday's session. The company priced its public offering of 5 million shares of common stock at $0.85 per share.
Via Benzinga · January 10, 2025

Via Benzinga · January 10, 2025

Via Benzinga · January 10, 2025

Via Benzinga · November 14, 2024

Via Benzinga · November 14, 2024

Via Benzinga · November 13, 2024

CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024

Via Benzinga · July 8, 2024

Calidi Biotherapeutics shares are trading lower by 14.3% during Monday's session. The company announced a 1-for-10 reverse stock split.
Via Benzinga · July 8, 2024

Via Benzinga · June 12, 2024

Via Benzinga · June 12, 2024

Via Benzinga · June 12, 2024

Via Benzinga · June 12, 2024

Via Benzinga · June 11, 2024

Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.
Via Benzinga · June 10, 2024

Via Benzinga · June 10, 2024

Via Benzinga · June 5, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning!
Via InvestorPlace · June 5, 2024